Dr. Michael B. Bradshaw, MD

Dr. Bradshaw practices at Insight Dermatology in San Diego, California.

Dr. Bradshaw's NPI, 1861646267, was assigned on November 11, 2008. Dr. Bradshaw graduated from Medical College Of Wisconsin in 2008. Dr. Bradshaw's California license number on file is A118993.

Dr. Bradshaw's primary practice is Insight Dermatology, at 10672 Wexford St, San Diego, CA 92131 in San Diego County. The practice phone is (858) 693-3000.

Dr. Bradshaw's primary practice is Insight Dermatology in San Diego, California. The medical group on file is Insight Dermatology. Dmand AI also links Dr. Bradshaw to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bradshaw practices. Vendor and product names are available with a free account.

Dermatology is Dr. Bradshaw's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bradshaw is board certified in dermatology by the American Board of Dermatology. Dr. Bradshaw has a license on file in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes, psoriasis and scalp rash among the conditions Dr. Bradshaw treats.

CMS data shows 3,283 Medicare services from Dr. Bradshaw across 13 procedure codes in 2024, for 500 Medicare patients. Medicare paid $125,887 for them. Every service was in an office.

CMS counts 500 Medicare patients who saw Dr. Bradshaw in 2024. The largest group is 65 to 74, with 250 patients. 66% of them have high cholesterol, and 62% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bradshaw's median patient age at 67, with 45% women.

In 2024, Dr. Bradshaw wrote 1,338 Medicare Part D claims for 446 patients. 89% of them were for generic drugs. CMS names the drug for 1,130 of them, across 32 drugs with 11 or more claims each, at $513,973 in total drug cost. In 2023, CMS named 830 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Bradshaw for performance year 2024, reported individually. Dr. Bradshaw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 886 procedures of removal of skin lesions by Dr. Bradshaw, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Bradshaw.

CMS Open Payments shows 1,250 general payments to Dr. Bradshaw from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Amgen Inc. paid the most, $105,453.

Dmand AI lists 1 award for Dr. Bradshaw, most recently CMS Stage 1 EHR in 2013.

Dr. Bradshaw graduated from Medical College Of Wisconsin in 2008.

Dr. Bradshaw is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.